EPHA2 and breast cancer: Further investigations showed that EphA2 expression was positively correlated with YAP/TAZ nuclear localization in HER2+ BC, and YAP/TAZ-mediated glutaminolysis could predict enhanced metastatic potential and poor patient survival [65].